Recently, caspase-2 was shown to act upstream of mitochondria in stress-induced apoptosis. Activation of caspase-8, a key event in death receptor-mediated apoptosis, has also been demonstrated in death receptor-independent apoptosis. The regulation of these initiator caspases, which trigger the mitochondrial apoptotic pathway, is unclear. Here we report a potential regulatory role of caspase-2 on caspase-8 during ceramide-induced apoptosis. Our results demonstrate the sequential events of initiator caspase-2 and caspase-8 activation, Bid cleavage and translocation, and mitochondrial damage followed by downstream caspase-9 and -3 activation and cell apoptosis after ceramide induction in T cell lines. The expression of tBid and reduction in mitochondrial transmembrane potential were blocked by caspase-2 or caspase-8, but not caspase-3, knockdown using an RNA interference technique.
INTRODUCTION
Western Blot Analysis To detect cytochrome c release, cytosolic extract without the mitochondrial fraction was separated using an ApoAlert Cell Fractionation Kit (Clontech), according to the manufacturer's instructions. To detect other proteins, total cell lysate was used. Western blotting was then performed (BD Biosciences). Briefly, cell extract was separated by SDS-PAGE, and then transferred to PVDF membrane (Millipore). After blocking, blots were developed with a series of antibodies as indicated. Rabbit antibodies specific for mouse caspase-2, -3, -8, -9, poly(ADP-ribose) polymerase (PARP), cytochrome c (Santa Cruz Biotechnology), and tBid (Oncogene) were used. Monoclonal antibodies against human caspase-2 and -8 (R&D) and -actin (Sigma), and rabbit antibodies against human caspase-3 and -9 (Cell Signaling Technology) and green fluorescent protein (GFP) (Santa Cruz Biotechnology) were used. Finally, blots were hybridized with horseradish peroxidase-conjugated goat anti-rabbit IgG or anti-mouse IgG (Calbiochem) and developed using an AEC substrate kit (Zymed).
Mitochondrial Functional Assay The mitochondrial transmembrane potential (MTP,
Immunostaining For intracellular immunostaining, cells were fixed with 1% paraformaldehyde in PBS and permeabilized with 0.01% Triton X-100 in PBS. A series of antibodies were used as indicated, followed by fluorescein isothiocyanate (FITC)-conjugated goat anti-rabbit IgG (Calbiochem) staining. Rabbit anti-tBid was used for flow cytometric analysis. For confocal microscopy, rabbit anti-tBid and anti-cytochrome c (Calbiochem) antibodies were used. Mito Tracker Red CMXRos and DAPI were used for mitochondrial and nuclear staining, respectively.
Caspase-2, -3, and -8 Short Interfering RNA (siRNA) Preparation Plasmids expressing
short hairpin RNA were constructed using standard techniques. The pSUPER/enhanced GFP (EGFP) contained the GFP gene from pEGFP-N1 (Clontech) inserted into the pSUPER vector (28; kindly provided by Dr. R. Agami, The Netherlands Cancer Institute, Amsterdam, Netherlands). To generate pSUPER-Casp2/EGFP, the pSUPER/EGFP was digested with BglII and HindIII and the annealed targeting oligonucleotides ACAGCTGTTGTTGAGCGAA (14) were ligated into the vector. To generate pSUPER-Casp3/EGFP and pSUPER-Casp8/EGFP, the pSUPER/EGFP was digested with BglII and HindIII and the annealed targeting oligonucleotides TGACATCTCGGTCTGGTAC (29) and GTTCCTGAGCCTGGACTAC (30) were ligated into the vector, respectively. The pSUPER-Casp2 (3 or 8)/EGFP/Neo was generated by
RESULTS AND DISCUSSION
Ceramide Induces Caspase-dependent and Mitochondria-mediated Apoptosis We used ceramide to induce apoptosis in 10I T hybridoma cells. The time kinetics of ceramide-induced cell apoptosis was shown by PI staining and TUNEL reaction followed by flow cytometric analysis (Fig. 1A) . Using a caspase activity assay and Western blot analysis, the activity of caspase-9 and -3 ( Fig. 1A) and the presence of active forms of caspase-9 (33 kDa) and -3 (17 kDa) and caspase substrate PARP cleavage (Fig. 1B) were observed after exposure to ceramide. Cell death, caspase activation, and PARP cleavage were blocked by z-VAD-fmk pretreatment. In addition, the irreversible caspase-9 and -3 inhibitors, z-LEHD-fmk and z-DEVD-fmk, respectively, blocked cell apoptosis as compared with DMSO controls (Fig. 1C) . Caspase-9 activity was inhibited by z-VAD-fmk and z-LEHD-fmk, but not by z-DEVD-fmk.
Using lipophilic cationic fluorochrome (rhodamine 123 and DiOC 6 (3)) staining and WST-8 assay, we found that ceramide induced mitochondrial transmembrane potential (MTP, m ) reduction and mitochondrial dehydrogenase activity downregulation in a time-dependent manner (data not shown). To study whether mitochondrial damage is the essential event involved in the ceramide-mediated apoptotic feature, a mitochondrial permeability transition pore inhibitor, bongkrekic acid (BA), was used (22, 31, 32) . Using rhodamine 123 and PI staining followed by flow cytometric analysis, we found that pretreatment with BA blocked ceramide-induced m reduction and cell apoptosis (Fig. 1D) .
Consistently, both ceramide-induced caspase-9 and -3 activation (Fig. 1D ) and cytosolic cytochrome c expression (Fig. 1E) Fig. 2A) . The onset of caspase-2 activity occurred earlier than that of caspase-8 ( Fig. 2A, left panel) . However, the caspase-2 cleavage form exhibited a higher level at a later time ( Fig. 2A, right panel) . It was recently reported that caspase-2 activation might occur by oligomerization without any significant processing of procaspase-2 (33). Our data may implicate the activation of caspase-2 at an early stage without marked processing of the precursor, and its cleavage at the late stage may be a result of the activity of caspase-3 as previously suggested (34). This hypothesis remains to be tested.
We next investigated whether these initiator caspases were required during Western blot analysis using tBid-specific antibody ( Fig. 2A, right panel) . Further approaches using the tBid-specific antibody in combination with Mito Tracker dye showed the translocation of tBid to mitochondria in ceramide-treated apoptotic cells (Fig. 2C) . Also, by flow cytometric analysis, ceramide-enhanced tBid expression was shown (Fig. 2D) .
Interestingly, Bid cleavage and cytochrome c release after ceramide stimulation were blocked by z-VDVAD-fmk or z-IETD-fmk pretreatment (Fig. 2, C-E) . Therefore, activation of initiator caspases, including caspase-2 and -8, are necessary for tBid expression and translocation.
Sequential Activation of Caspase-2 and -8 in Ceramide-and Etoposide-induced
Mitochondrial Apoptosis To examine the regulatory relationship between initiator caspases, we verified the association of caspase-2 deficiency with defective caspase-8 activation by caspase inhibitors or an RNA interference approach. We first inactivated caspase-2 and -8 in 10I cells by pretreatment with z-VDVAD-fmk and z-IETD-fmk, respectively. Results showed that pretreatment with z-VDVAD-fmk, but not with z-IETD-fmk, suppressed caspase-2 activity in response to ceramide stimulation. By contrast, caspase-8 activation was blocked by both z-IETD-fmk and z-VDVAD-fmk (Fig. 3A) . Therefore, caspase-2 is required for ceramide-induced caspase-8 activation. When 10I cells were treated with etoposide, the results obtained were similar; pretreatment with z-VDVAD-fmk blocked both caspase-2 and -8 activity, whereas pretreatment with z-IETD-fmk blocked only caspase-8 activity (Fig. 3A) .
To further confirm these results, we introduced the short hairpin RNA specific for caspase-2 ( siRNA-expressing cells, which were collected by sorting of EGFP-positive cells (Fig. 3C ).
Impaired activity of caspase-2, -3, and -8 were observed when compared to the untransfected (wild-type, WT) and vector controls in ceramide-treated cells (Fig. 3D) . Similarly, caspase-2 siRNA-expressing cells were defective in caspase-8 activation compared to the wild-type and vector controls after etoposide treatment (Fig. 3D) . We also introduced the short hairpin RNA specific for caspase-8 and -3 into Jurkat T cells for interference with caspase-8 and -3 expressions, respectively (Fig. 3C ). Impaired activity of caspase-3 and -8, but not caspase-2,
were observed when compared to the wild-type and vector controls in ceramide-treated caspase-8 siRNA-expressing cells. Impaired activity of caspase-3, but not caspase-2 and -8, was observed in ceramide-treated caspase-3 siRNA-expressing cells (Fig. 3D ).
In Fig. 2 , we showed that ceramide-induced tBid expression and m reduction were blocked when cells were treated with caspase-2 and -8 inhibitors. These results were further consolidated in caspase-2, -3, and -8 knockdown cells. In the caspase-3 siRNA-expressing cells, ceramide-induced tBid expression (Fig. 4A ) and m reduction (Fig. 4B) as detected receptor-independent pathway are poorly defined. Here we show that T cell apoptosis induced by ceramide and etoposide is associated with an initiator caspase-mediated mitochondria-dependent pathway. In this pathway, active caspase-8 causes Bid cleavage and translocation of tBid to mitochondria that result in mitochondrial permeabilization. Most importantly, activation of caspase-2 is required for caspase-8 activation before the permeabilization of mitochondria (Fig. 6) . A recent report (39) showed that both caspase-2 and caspase-8 were activated in HOXA5-induced apoptosis of breast cancer cells, yet the sequential activation of these two caspases was not demonstrated. Another study showed that the marine alkaloid ascididemin induced Jurkat T cell apoptosis that required caspase-2 activation upstream of mitochondria and caspase-8 activation as an effector caspase downstream of mitochondria (40) . The present study is, to our knowledge, the first to show that caspase-2 may act upstream of caspase-8 before mitochondria damage. A previous report (41) 
